semaglutide compounding news november 2025 Drug compounders sue FDA over declaration ending Wegovy shortage Novo Nordisk further lowers prices – FDA and Novo Nordisk Warned

If you experience any side effects while taking Semaglutide GLP-1, it is important to notify your doctor right away

Patients should feel empowered to ask questions, express concerns, and participate actively in shared decision-making regarding their weight management treatment plan

Clinical Evidence: Divergent Roles in Diabetes and Gastrointestinal Health GLP-1 agonists have extensive regulatory approval and outcome trials spanning type 2 diabetes and chronic weight management

Tirzepatide, the first dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) RA approved for both conditions, has paved the way for next-generation incretin-based therapies

Some people pay much less per month when combining insurance coverage with manufacturer savings programs